Dementia research institute to double U.K. coronavirus testing
Publication date: 25 March 2020
While science groups worldwide are grappling with the logistics of shutting down to comply with the social distancing required to slow the spread of COVID-19, neurodegenerative disease researchers are asking how they can help. And help they can.
One lab at Imperial College London is poised to double current SARS-CoV-2 testing capability in the U.K. Paul Freemont and colleagues have repurposed their high-throughput, robotic rtPCR technology to crank out up to 10,000 tests per day. As of writing, the whole of the U.K. was completing about 10,000 tests a day, though that is set to scale up rapidly in the coming weeks.